Match tier
Listed
Presence
Current · Arkansas
Last published
2025
Sources
OpenAlex · ORCID
Refreshed
2026-08-15
Biography and Research Information
OverviewAI-generated summary
Kennith Swafford's research focuses on investigating therapeutic targets and molecular mechanisms in cancer, particularly within lymphoma and lung carcinoma. His work has explored novel compounds and their effects on oncogenic pathways. Recent publications highlight the identification of NEK2 as a potential therapeutic target in lymphoma and the targeting of specific DNA structures, such as G-quadruplexes, within the promoters of oncogenes like CARD11 and MYD88.
Swafford also studies the formation of these DNA structures in key immune response genes. He has a significant publication record, with 57 total publications and an h-index of 3. His collaborations at the University of Arkansas for Medical Sciences include extensive work with Mason McCrury, Vijay Patel, Ying-Zhi Xu, and Claire Doshier, with whom he shares a substantial number of co-authored publications.
Metrics
- h-index: 3
- Publications: 57
- Citations: 30
Selected Publications
-
G-quadruplex and i-motif DNA structures form in the promoter of the key innate immune adaptor MYD88 (2025)
Collaboration Network
Top Collaborators
Mason McCrury
University of Arkansas for Medical Sciences
3 shared publications
In database
- Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
- Targeting a Novel G-Quadruplex in the CARD11 Oncogene Promoter with Naptho(2,1-b)furan-1-ethanol,2-nitro- Requires the Nitro Group
- G-quadruplex and i-motif DNA structures form in the promoter of the key innate immune adaptor MYD88
Samantha Kendrick
University of Arkansas for Medical Sciences
3 shared publications
In database
- Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
- Targeting a Novel G-Quadruplex in the CARD11 Oncogene Promoter with Naptho(2,1-b)furan-1-ethanol,2-nitro- Requires the Nitro Group
- G-quadruplex and i-motif DNA structures form in the promoter of the key innate immune adaptor MYD88
Baku Acharya
University of Arkansas for Medical Sciences
2 shared publications
In database
- Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
- Targeting a Novel G-Quadruplex in the CARD11 Oncogene Promoter with Naptho(2,1-b)furan-1-ethanol,2-nitro- Requires the Nitro Group
Ying-Zhi Xu
University of Arkansas for Medical Sciences
2 shared publications
In database
- Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
- Targeting a Novel G-Quadruplex in the CARD11 Oncogene Promoter with Naptho(2,1-b)furan-1-ethanol,2-nitro- Requires the Nitro Group
Debasmita Saha
University of Arkansas for Medical Sciences (US)
2 shared publications
- Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
- Targeting a Novel G-Quadruplex in the CARD11 Oncogene Promoter with Naptho(2,1-b)furan-1-ethanol,2-nitro- Requires the Nitro Group
Brendan Frett
University of Arkansas for Medical Sciences
2 shared publications
In database
- Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
- Targeting a Novel G-Quadruplex in the CARD11 Oncogene Promoter with Naptho(2,1-b)furan-1-ethanol,2-nitro- Requires the Nitro Group
Thomas Raney
University of Arkansas for Medical Sciences
1 shared publication
In database
- Targeting a Novel G-Quadruplex in the CARD11 Oncogene Promoter with Naptho(2,1-b)furan-1-ethanol,2-nitro- Requires the Nitro Group
Sydnye L. Shuttleworth
University of Arkansas for Medical Sciences
1 shared publication
In database
- Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
Syed Hassan Mehdi
University of Arkansas Medical Center
1 shared publication
In database
- Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
Kevin Naceanceno
University of Arkansas for Medical Sciences (US)
1 shared publication
- Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
Stephanie D. Byrum
Arkansas Children's Hospital
1 shared publication
In database
- Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
Aaron J. Storey
University of Arkansas for Medical Sciences
1 shared publication
In database
- Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
Claire Doshier
University of Arkansas for Medical Sciences
1 shared publication
In database
- Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
Vijay Patel
University of Arkansas for Medical Sciences
1 shared publication
In database
- Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
Ginell R. Post
University of Arkansas for Medical Sciences
1 shared publication
In database
- Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
Similar Researchers
Based on overlapping research topics
Saad A. Mahmoud
University of Arkansas for Medical Sciences
Cancer-related molecular mechanisms research
Lung Cancer Diagnosis and Treatment
Disease Mechanisms Research
Md Nazmul Huda
University of Arkansas for Medical Sciences
Cancer-related molecular mechanisms research
Disease Mechanisms Research
Molecular Biology Techniques and Applications
Trent R. Percy
University of Arkansas – Fort Smith
Cancer-related molecular mechanisms research
Lung Cancer Diagnosis and Treatment
Disease Mechanisms Research
Vijay Patel
University of Arkansas for Medical Sciences
Cancer-related molecular mechanisms research
Lymphoma Diagnosis and Treatment
Disease Mechanisms Research
Mason McCrury
University of Arkansas for Medical Sciences
Cancer-related molecular mechanisms research
Lymphoma Diagnosis and Treatment
Lung Cancer Diagnosis and Treatment
Alyssa Rowland
Arkansas State University
Cancer-related molecular mechanisms research
Molecular Biology Techniques and Applications
Receptor Mechanisms and Signaling